Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NK or T-Cell Adback Post-AlloSCT for Lymphoid Malignancies
NCT00536978Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2007
- Primary completion
- Nov 2010
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of donor natural killer cell infusion in lymphoma, leukemia, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2007; status: completed.
02
Drugs
donor natural killer cell infusion
03
Conditions
lymphomaleukemia
Beyond the preview
Go deeper on NCT00536978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536978.